Weak organic growth masks AI pivot; execution risk on recovery claims
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met guided EBIT margin expansion (+120 bps YoY), stable order book, and deal wins. Missed growth acceleration narrative: Q1 CC growth 6.4% vs prior call's 'surpass FY2026 levels' claim.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
LTM delivered 18% YoY PAT growth but 6.4% organic revenue growth flat vs FY2026, signaling deceleration masked by FX and accounting gains. AI pivot is structural (USD 150M quarterly run rate, strong deal pipeline), but near-term growth acceleration risks (India deal ramp delayed, Consumer segment still negative QoQ, discretionary spend limited, 15–20% pricing deflation on new deals). Margins expanding via operational efficiency (New Horizons program) and forex offset wage hikes, but unsustainable if deflation persists. Randstad deal (Q3 expected) a multi-year bet requiring execution.
₹11608 Cr
Revenue · +18% YoY₹1468.6 Cr
Reported PAT · +17.1% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
0.3% QoQ growth in constant currency; strong sequential expansion
OVERSTATED2.8% QoQ INR growth, 0.3% CC growth is well below historical 3-4% range; BFSI +3.2%, Tech +3.4%, but Consumer -0.7% dragged headline
6.4% YoY constant currency growth reflects strong execution
MISS6.4% YoY CC growth is essentially flat vs FY2026's 6% guidance baseline and below historical 8-10% trends; no acceleration yet
Productivity headwinds in top accounts behind us; new deals built on new pricing
OVERSTATEDOld deals finalized at prior rates; new order book at 15-20% lower price points due to AI productivity (management admitted in Q&A), representing ongoing pricing deflation masked as 'new reference point'
EBIT margin 15.5% with 40 bps QoQ improvement and 120 bps YoY improvement
METDelivered OPM 17.8%, NPM 12.4%; discrepancy in EBIT vs OPM definition; forex offset wage hike per management, operational efficiency gain understated
AI revenue USD 150M quarterly run rate; measurable business outcomes and strong deal wins
METUSD 150M is ~1.3% of quarterly revenue (₹11,608 Cr = ~$1.4B); only 17 unique Voicing implementations in 12 months total; AI still nascent despite branding
Growth will accelerate through Q2 and into second half, surpassing FY2026 levels
MISSQ1 shows 6.4% YoY CC growth (no acceleration vs FY2026's 6%). Requires ~8%+ CQGR Q2-Q4 to beat FY2026. India deal ramp delayed into Q2, Consumer still negative QoQ, discretionary spend limited—execution risk high
Earnings quality
What changed since the last call
Growth narrative downgraded by numbers
DowngradePrior call: 'growth accelerate…surpassing FY2026 levels.' Q1 delivered 6.4% YoY CC growth vs FY2026's 6% — no acceleration, flat to down. Requires 8%+ CQGR rest of year to beat prior year; high execution risk.
Margin expansion narrowly confirmed
UpgradeYoY EBIT margin +120 bps delivered (15.5% vs 14.3% prior year Q1). QoQ +40 bps despite wage hikes. New Horizons program driving operational efficiency gains offset forex & subcon headwinds. Confidence in sustainable expansion at 15.5–16%+ range.
Productivity deflation framed as 'behind us'
NeutralTop client pricing cuts finalized in FY26. Q1 shows new deals priced 15–20% lower than prior year due to AI productivity — a new equilibrium, not a one-time cliff. Ongoing challenge masked as transition.
AI work still nascent, but strategic
NewUSD 150M quarterly run rate (1.3% of revenue) across Creative/Industrial/Business AI. 17 Voicing implementations in 12 months. Small base but growing; significant revenue contribution years away, not near-term driver.
Guidance maintained; delivery lags
NeutralNo formal guidance change, but organic growth lags implication of prior 'acceleration' message. Order book stable but deflated in pricing. Execution risk on deal ramps and macro uncertainty cited but not quantified.
The Q&A
Analysts pressed on whether productivity deflation is truly behind (it's not—embedded in new deals), whether top clients have permanently switched to AI-productivity pricing (yes, at 15–20% discount), and whether discretionary spend will recover (management uncertain; limited to AI/revenue/margin initiatives). Management held firm on growth acceleration thesis and margin resilience but offered limited specifics on macro timing. Confidence tone was defensive—emphasizing 'phase behind us' repeatedly rather than aggressive outlooks.
Growth acceleration and forecast — Sulabh Govila, Morgan Stanley
PartialBiggest segments (BFSI, Tech) in growth trajectory. Seasonal pass-through, Middle East geopolitical, India ramp delays are temporary. Expect Q2 momentum to continue despite macro headwinds. Productivity transition complete in top clients.
Vendor consolidation and subcontracting — Ashwin Mehta, Ambit Capital
AnsweredVendor consolidation transition deals where clients expect continuity of existing resources before handoff to LTM team. Temporary spike; will normalize as transition completes. Not indicative of broader trend.
Productivity gains and pricing — Hasmukh Vakharia, (implied)
AnsweredAI conversation moved from creation phase (last year) to deployment phase (now). New deals priced with AI productivity baked in; conversation has shifted from old pricing to new AI-enabled pricing construct. Largest deals won this quarter already factor in new pricing.
Order book and deal velocity — Hasmukh Vakharia
AnsweredOrder book has natural deflation adjustment (15% lower price points on new deals vs FY2026). Delivering more work for same dollar value. Geopolitical headwinds and limited discretionary spend constrain deal sizes. Preference for consistency over one-off spikes.
Consumer segment weakness — Rohit Thorat, Axis Capital
AnsweredYoY growth huge (+18.2%). QoQ decline due to delayed ramp-ups on large deals (India tax department, hardware shipments, memory chip delays). Marginal decline; positive on recovery once shipments accelerate.
North America momentum — Rohit Thorat
AnsweredTech services +3.4% QoQ, +10% YoY (double-digit). BFSI also back to sequential growth. Confident momentum will continue; North America has great traction built up.
Utilization and fresher hiring — Rohit Thorat
AnsweredTargeting 86–87% utilization range; currently mid-range, comfortable. Added 1,308 freshers Q1; expect similar numbers each quarter, possibly accelerate. AI-ready talent critical to strategy. Pyramid shape to shift from traditional to diamond over time.
Margins under growth acceleration — Sandeep Shah, Equirus
AnsweredOrganic margin to expand due to New Horizons initiatives. Randstad deal is 360-degree relationship (IT services + talent sourcing + M&A). No investment banking costs (direct transaction). Margins should track last year or better.
AI deflation scope — Sumeet Jain, CLSA
PartialProductivity headwinds in top accounts material in FY26. Now past that phase. New deals priced with AI productivity embedded. Conversation shifted to ROI and adoption, not model capability. Most top clients through phase already.
Five-year revenue doubling target — Sumeet Jain
PartialEuropean expansion via Randstad (Q3 onwards). APAC white space. AI work scaling (currently USD 150M quarterly). All new deals priced lower but with better margins. Limited discretionary spend now; expected to improve. Multiple levers to drive ambition.
Voicing.AI and Uniphore investments — Sushovan Nayak, Anand Rathi
AnsweredVoicing.AI: conversion of safe/preferred stock to equity triggered one-time fair-value gain through P&L. Going forward, fair-value changes in OCI. Voicing transforms contact centers and business processes; 17 implementations in 12 months. Uniphore: investment in equity round to accelerate SLM platform and partnership. Amounts not disclosed (private round, company confidentiality).
AI 1000 initiative timeline — Rahul Jain, Dolat Capital
Answered1,000 FDEs first cohort, Q2–Q3 majority skilling complete. Contextual/domain training in parallel with customers. Only few thousand FDEs globally available; massive opportunity for adoption acceleration. Not need 20k–30k; thousand makes significant impact.
Top client recovery confirmation — Vibhor Singhal, Nuvama
AnsweredSimple answer: yes. Headwinds complete; productivity transition done. Both clients grew this quarter; pipeline strong.
Randstad margin impact and tail rationalization — Vibhor Singhal
PartialRegulatory approval process on track; closure expected Q2 end or Q3 beginning. Transformation activities constrained until close. Assume prior shared numbers as safe baseline for now. No significant margin impact expected; deal has three legs (IT services, talent outsourcing, tech/digital M&A) with savings and synergies. Margin trajectory organic expansion continues; Q1-Q2 may see impact, but year margin should not degrade vs prior year.
Pricing deflation embedded in new deals — Prateek, HSBC
AnsweredFair characterization but not pure deflation. Same requirement priced 15% higher a year ago; now priced 15% lower due to new AI productivity. Price point is new reference point. Order book normalizes for this; delivering more work at same dollar value.
Deal productivity cuts history — Anmol Garg, DAM Capital
AnsweredAll productivity headwinds in top accounts last year; phase behind us. New deals priced per new productivity levels. Most existing big deals passed that phase. New book is new book; no regression.
Guidance
FY2027 organic growth better than FY2026's 6%
MediumRequires 8%+ CQGR from Q2–Q4. Q1 at 6.4% CC growth not supporting narrative yet. Depends on India deal ramp-up (Q2), Randstad IT services contribution (Q2 onwards), and Consumer recovery. Macro uncertainty and limited discretionary spend create downside risk.
EBIT margin to continue expansion; target 15.5%+ sustainable
HighNew Horizons program delivering 40 bps QoQ improvement Q1. Operational efficiency (G&A headcount reduction on AI adoption, vendor consolidation) offset wage hikes (~1%) and forex impacts. SG&A to stabilize at ~10% of sales (vs prior 11%–11.5% guidance).
Risks the call surfaced
Growth deceleration
HighQ1 6.4% YoY CC growth flat vs FY2026; requires 8%+ CQGR H2 to beat FY2026 target. India deal delayed, Consumer segment QoQ negative, discretionary spend limited. Execution risk on catalysts (Randstad, India ramp, macro recovery) high.
Pricing deflation
HighNew order book priced 15–20% lower than FY2026 due to AI productivity gains. Management frames as 'new pricing construct' but masks ongoing revenue headwind. Order book stable USD 1.7B but delivers more work at lower unit price. Margin expansion dependent on utilization/efficiency gains, not pricing power.
Customer concentration
MediumIndia government deal delayed due to supply chain issues (hardware, memory); ramp-up pushed to Q2 with timing risk. Randstad acquisition expected Q3; initial margin impact unclear (amortization, integration costs). Both are material to FY27 growth guidance; delays create miss risk.
Competitive pressure from hyperscalers
MediumMicrosoft announced 6,000 FDEs + $2–3B investment; other hyperscalers ramping similar initiatives. LTM AI 1000 FDE program positions LTM as complementary, but hyperscaler integration/consulting orgs could disintermediate. Long-term positioning risk if hyperscalers capture deployment-phase upside.
Macro/geopolitical headwinds
MediumMiddle East revenue <3% but delays Consumer ramp-ups. Discretionary spend remains limited (clients prioritizing AI/revenue/margin initiatives). Geopolitical escalation could further constrain capex budgets. Management indicated 'limited appetite' on discretionary spend; no sign of full recovery by H2 FY27.
Management
Score 6/10. Clear on strategy (AI pivot, three LoB model) but defensive on near-term execution. Repeatedly framed challenges as 'phase behind us' without quantifying path forward. Transparent on pricing deflation magnitude (15–20%) but initially presented as strategy, not headwind. Candid on macro risks; appropriately cautious on discretionary spend. Met margin expansion target (+120 bps YoY); delivered on EBIT margin guidance. Deal pipeline confirmed with named wins (though unquantified). Failed to deliver growth acceleration narrative—Q1 organic growth flat vs FY2026. Track record on prior guidance execution: Fit4Future program delivered results; New Horizons in early stages.
1 · Q2 FY27
India government large deal hardware delivery expected; ramp-up in revenue contribution
2 · Q2 FY27 onwards
Randstad IT services revenue ramp-up begins; transition to internal delivery model
3 · Q3 FY27
Randstad acquisition expected to close; full margin impact from synergies to begin
Randstad deal (Q3 expected) a multi-year bet requiring execution.
Informational and educational content only. Not investment advice.